Skip to main content

Leukemia: 21-279

Trial ID
Trial Sponsor

A Phase 2 Trial of Zanubrutinib and Venetoclax in Previously Treated CLL/SLL Patients

ANNOUNCEMENT: We no longer accept cash payments.

X

By using this website, you agree to the use of cookies and our privacy policy.

X